Author details

Full Name

Yu Shen

Affiliation

ORCID

Career Start Year

1996

Papers

214

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37751792	Racial and Ethnic Differences in Long-Term Adverse Radiation Therapy Effects Among Breast Cancer Survivors.	Int J Radiat Oncol Biol Phys	2024
37348833	Comparisons of Medical Cost Trajectories Between Non-Hispanic Black and Non-Hispanic White Patients With Newly Diagnosed Localized Prostate Cancer.		2023
36250944	Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.	J Urol	2023
36346180	Disparity in checkpoint inhibitor utilization among commercially insured adult patients with metastatic lung cancer.	Journal of the National Cancer Institute	2023
37566192	Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.		2023
37961619	Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling.	Res Sq	2023
37211780	Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.	J Urol	2023
37210470	Evaluation of the natural history of disease by combining incident and prevalent cohorts: application to the Nun Study.		2023
36900406	Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients.	Cancers (Basel)	2023
37458948	Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.	Ann Surg Oncol	2023
37382943	Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer.		2023
37377604	Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.	Cancer Res Commun	2023
36741254	Effectiveness Without Efficacy: Cautionary Tale from a Landmark Breast Cancer Randomized Controlled Trial.	J Cancer	2023
37232937	Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and Reconstruction.	Ann Surg	2023
36856291	Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint.		2023
35133007	Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study.	Int J Cancer	2022
36306810	Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial.	Lancet Oncol	2022
36353187	Semiparametric copula-based regression modeling of semi-competing risks data.	Communications in Statistics - Theory and Methods	2022
36352359	SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study.	BMC Infectious Diseases	2022
35491652	Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.	Clin Cancer Res	2022
36199482	Impact of Medicaid Expansion Under the Affordable Care Act on Receipt of Surgery for Breast Cancer.	Ann Surg Open	2022
34745408	ESTROGEN RECEPTOR EXPRESSION ON BREAST CANCER PATIENTS' SURVIVAL UNDER SHAPE RESTRICTED COX REGRESSION MODEL.	Annals of Applied Statistics	2021
35707737	A Bayesian semiparametric method for analyzing length-biased data.	Journal of Applied Statistics	2021
34071219	Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer.	Cancers (Basel)	2021
34226566	Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis.	NPJ Breast Cancer	2021
33735487	Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis.	Cancer	2021
33528758	Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.	Breast Cancer Research and Treatment	2021
33785875	Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer.	Br J Cancer	2021
33942352	Design of phase III trials with long-term survival outcomes based on short-term binary results.	Statistics in Medicine	2021
33557032	The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy.	Cancers (Basel)	2021
33556275	Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.	Annals of Internal Medicine	2021
34327874	Inflammatory breast cancer appearance at presentation is associated with overall survival.	Cancer Med	2021
33210440	The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-GuÃ©rin.	BJU Int	2021
32827153	Combining primary cohort data with external aggregate information without assuming comparability.	Biometrics	2021
33086432	Analyzing left-truncated and right-censored infectious disease cohort data with interval-censored infection onset.	Statistics in Medicine	2021
33417121	Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.	Ann Surg Oncol	2021
31503277	Time to Consider a Personalized Approach to Incorporate Tomosynthesis Into Routine Breast Cancer Screening.	Journal of the National Cancer Institute	2020
31849202	Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer.	Cancer Med	2020
32003919	Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2-Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab.	Oncologist	2020
32047541	Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes.	J Cancer	2020
31667721	Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.	Ann Surg Oncol	2020
31916092	Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.	Ann Surg Oncol	2020
34269395	Statistical modeling of longitudinal medical cost trajectory: renal cell cancer care cost analyses.	Biostatistics	2020
33046869	Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.	Nat Med	2020
33133648	CoxPhLb: An R Package for Analyzing Length Biased Data under Cox Model.	R Journal	2020
32739138	Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective.	Surgery	2020
32672820	Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer.	JAMA Oncol	2020
31097774	A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.	Br J Cancer	2019
31605340	Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden.	Ann Surg Oncol	2019
28742682	Ductal Carcinoma In Situ and Margins <2â¿¿mm: Contemporary Outcomes With Breast Conservation.	Ann Surg	2019